Regarding the impact of TNF inhibitors on the immune response to the COVID-19 vaccine, the quality of the evidence is low and does not allow for firm conclusions to be drawn since some authors have described diminished serological and cellular responses in these patients, and others have reported that immunogenicity is not hampered. Here, TNF is linked to COVID-19.